Skip to main content
. Author manuscript; available in PMC: 2018 Jun 2.
Published in final edited form as: Stem Cells. 2016 Sep 20;35(2):351–361. doi: 10.1002/stem.2484

Figure 3. Overexpression of YAP attenuated differentiation of VSMCs.

Figure 3

(A)(B): Overexpression of YAP decreased expression of VSMC contractile markers by RT-qPCT (A) and western blot (B). (C): Quantification of decreased cell surface of VSMCs in Vector and YAP overexpressed group after Carbachol 100 uM for 30 min. (D): Quantification of decreased cell surface of VSMCs in Vector and YAP overexpressed group after 30 min angiotensin II 10 uM treatment in normal VSMCs or losartan 10 uM pretreated VSMCs (Losartan+ANG II). Results were shown as average ± SEM with three independent replicates and statistic analyzed with unpaired t-test, *p<0.05, ***p<0.001. ANG II: angiotensin II.